Geometry-Mediated Microgel Structure-Mechanics for Intestinal Region-Specific Probiotic Delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42764499.
- Also identified by DOI 10.1002/adma.75011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The physiological efficacy of functional food ingredients, particularly probiotics is highly dependent on their spatial localization within the intestine. The non-specific delivery of probiotics severely restricts their therapeutic efficacy. Herein, we developed a sustainable, food-grade microgel delivery platform assembled from corncob nanocellulose building blocks with distinct geometries for programmable intestinal probiotic release. Owing to their distinct topological structures and mechanical properties, spherical nanocellulose-based microgels (CNSM) were found to disintegrate in the ileum, while rod-like nanocellulose-based microgels (CNRM) retained intact until reaching the colon, where they subsequently ruptured. Molecular dynamics simulations supported the superior structural stability of CNRM against osmotic swelling, revealing a structure-mechanics driven mechanism for the controlled release pattern. Both microgels significantly enhanced probiotic survival, as well as nanocoating-mediated mucoadhesion and colonization. To maximize functionality, bile salt hydrolase-producing L. plantarum WCFS1 and immunomodulatory L. rhamnosus GG were embedded into CNSM and CNRM, respectively. Consequently, ileum-targeted WCFS1@CNSM significantly ameliorated hypercholesterolemia, accompanied by increased fecal cholesterol excretion and potential modulation of the gut-liver signaling axis whereas colon-targeted LGG@CNRM profoundly alleviated DSS-induced colitis through epithelial barrier restoration and inflammation suppression. This work provides a region-specific delivery strategy for next-generation probiotic therapeutics.